Literature DB >> 27680322

Twitter as a Potential Data Source for Cardiovascular Disease Research.

Lauren Sinnenberg1, Christie L DiSilvestro1, Christina Mancheno1, Karl Dailey1, Christopher Tufts1, Alison M Buttenheim2, Fran Barg3, Lyle Ungar4, H Schwartz5, Dana Brown1, David A Asch6, Raina M Merchant1.   

Abstract

IMPORTANCE: As society is increasingly becoming more networked, researchers are beginning to explore how social media can be used to study person-to-person communication about health and health care use. Twitter is an online messaging platform used by more than 300 million people who have generated several billion Tweets, yet little work has focused on the potential applications of these data for studying public attitudes and behaviors associated with cardiovascular health.
OBJECTIVE: To describe the volume and content of Tweets associated with cardiovascular disease as well as the characteristics of Twitter users. DESIGN, SETTING, AND PARTICIPANTS: We used Twitter to access a random sample of approximately 10 billion English-language Tweets originating from US counties from July 23, 2009, to February 5, 2015, associated with cardiovascular disease. We characterized each Tweet relative to estimated user demographics. A random subset of 2500 Tweets was hand-coded for content and modifiers. MAIN OUTCOMES AND MEASURES: The volume of Tweets about cardiovascular disease and the content of these Tweets.
RESULTS: Of 550 338 Tweets associated with cardiovascular disease, the terms diabetes (n = 239 989) and myocardial infarction (n = 269 907) were used more frequently than heart failure (n = 9414). Users who Tweeted about cardiovascular disease were more likely to be older than the general population of Twitter users (mean age, 28.7 vs 25.4 years; P < .01) and less likely to be male (59 082 of 124 896 [47.3%] vs 8433 of 17 270 [48.8%]; P < .01). Most Tweets (2338 of 2500 [93.5%]) were associated with a health topic; common themes of Tweets included risk factors (1048 of 2500 [41.9%]), awareness (585 of 2500 [23.4%]), and management (541 of 2500 [21.6%]) of cardiovascular disease. CONCLUSIONS AND RELEVANCE: Twitter offers promise for studying public communication about cardiovascular disease.

Entities:  

Year:  2016        PMID: 27680322      PMCID: PMC5177459          DOI: 10.1001/jamacardio.2016.3029

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


  4 in total

1.  Exploring and developing consumer health vocabularies.

Authors:  Qing T Zeng; Tony Tse
Journal:  J Am Med Inform Assoc       Date:  2005-10-12       Impact factor: 4.497

2.  The Unified Medical Language System.

Authors:  D A Lindberg; B L Humphreys; A T McCray
Journal:  Methods Inf Med       Date:  1993-08       Impact factor: 2.176

3.  Psychological language on Twitter predicts county-level heart disease mortality.

Authors:  Johannes C Eichstaedt; Hansen Andrew Schwartz; Margaret L Kern; Gregory Park; Darwin R Labarthe; Raina M Merchant; Sneha Jha; Megha Agrawal; Lukasz A Dziurzynski; Maarten Sap; Christopher Weeg; Emily E Larson; Lyle H Ungar; Martin E P Seligman
Journal:  Psychol Sci       Date:  2015-01-20

4.  Personality, gender, and age in the language of social media: the open-vocabulary approach.

Authors:  H Andrew Schwartz; Johannes C Eichstaedt; Margaret L Kern; Lukasz Dziurzynski; Stephanie M Ramones; Megha Agrawal; Achal Shah; Michal Kosinski; David Stillwell; Martin E P Seligman; Lyle H Ungar
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  4 in total
  32 in total

1.  Tweeting the Meeting.

Authors:  Michael T Tanoue; Dhananjay Chatterjee; Heajung L Nguyen; Troy Sekimura; Brian H West; David Elashoff; William H Suh; Janet K Han
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-11

2.  Opioid Discussion in the Twittersphere.

Authors:  Rachel L Graves; Christopher Tufts; Zachary F Meisel; Dan Polsky; Lyle Ungar; Raina M Merchant
Journal:  Subst Use Misuse       Date:  2018-04-16       Impact factor: 2.164

3.  To Retweet or Not to Retweet: Understanding What Features of Cardiovascular Tweets Influence Their Retransmission.

Authors:  Qinghua Yang; Christopher Tufts; Lyle Ungar; Sharath Guntuku; Raina Merchant
Journal:  J Health Commun       Date:  2018-11-07

4.  It is time for Turkish Cardiologists to start engaging on Twitter.

Authors:  Göksel Çinier; Taylan Akgün; Tina Baykaner; Bulent Mutlu
Journal:  Turk Kardiyol Dern Ars       Date:  2019-09

5.  Buying Drugs Online in the Age of Social Media.

Authors:  Marcus A Bachhuber; Raina M Merchant
Journal:  Am J Public Health       Date:  2017-12       Impact factor: 9.308

6.  Social Media as an Emerging Data Resource for Epidemiologic Research: Characteristics of Regular and Nonregular Social Media Users in Nurses' Health Study II.

Authors:  Eric S Kim; Peter James; Emily S Zevon; Claudia Trudel-Fitzgerald; Laura D Kubzansky; Francine Grodstein
Journal:  Am J Epidemiol       Date:  2020-02-28       Impact factor: 4.897

Review 7.  Rare Cancers and Social Media: Analysis of Twitter Metrics in the First 2 Years of a Rare-Disease Community for Myeloproliferative Neoplasms on Social Media-#MPNSM.

Authors:  Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Jean-Jacques Kiladjian; Ruben Mesa; Michael A Thompson
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

8.  Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study.

Authors:  Noemí Martínez-López De Castro; Marisol Samartín-Ucha; Alicia Martín-Vila; Miriam Álvarez-Payero; Guadalupe Piñeiro-Corrales; José M Pego-Reigosa
Journal:  Eur J Hosp Pharm       Date:  2018-01-24

Review 9.  The Use of Social Media for Health Research Purposes: Scoping Review.

Authors:  Charline Bour; Adrian Ahne; Susanne Schmitz; Camille Perchoux; Coralie Dessenne; Guy Fagherazzi
Journal:  J Med Internet Res       Date:  2021-05-27       Impact factor: 5.428

Review 10.  Patient Education and Engagement through Social Media.

Authors:  Sravya Chirumamilla; Martha Gulati
Journal:  Curr Cardiol Rev       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.